1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : SPECIALTY PHARMACEUTICALS
  4. GUARDION HEALTH SCIENCES INC

Guardion Health Sciences Inc

XNAS: GHSI

Watchlist

Portfolio

Share
Board Meeting
The latest board meeting for Guardion Health Sciences Inc took place on 03 Apr 2025, for the purpose of Guardion Health Sciences Inc Third Quarter Earnings Results for 2024 See details


Insider Trading disclosures for Guardion Health Sciences Inc

The latest disclosure was made by Michaela Griggs in Guardion Health Sciences Inc where a trade of 334 Employee Stock Option (right to buy) done was reported to US exchanges on June 30, 2023.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Michaela Griggs Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2023 334 334 - - Employee Stock Option (right to buy)
Donald A. Gagliano Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2023 334 334 - - Employee Stock Option (right to buy)
Mark Goldstone Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2023 334 334 - - Employee Stock Option (right to buy)
Robert Neal Weingarten Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2023 334 334 - - Employee Stock Option (right to buy)
Janet Hall CEO & President Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 May 2023 10,000 10,000 - - Stock option (right to buy)
Michaela Griggs Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2022 16,667 16,667 - - Employee Stock Option (right to buy)
Donald A. Gagliano Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2022 16,667 16,667 - - Employee Stock Option (right to buy)
Mark Goldstone Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2022 16,667 16,667 - - Employee Stock Option (right to buy)
Robert Neal Weingarten Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2022 16,667 16,667 - - Employee Stock Option (right to buy)
Bret Scholtes Director, CEO and President Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.65 per share. 06 Jan 2022 37,175 294,980 (0%) 0% 0.7 24,164 Common Stock
Michaela Griggs Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Dec 2021 41,667 41,667 - - Stock Option (right to buy)
Donald A. Gagliano Director Purchase of securities on an exchange or from another person at price $ 1.25 per share. 30 Aug 2021 5,000 27,750 (0%) 0% 1.3 6,250 Common stock
Bret Scholtes Director, CEO and President Purchase of securities on an exchange or from another person at price $ 1.26 per share. 30 Aug 2021 4,500 173,984 (0%) 0% 1.3 5,656 Common stock
Bret Scholtes Director, CEO and President Purchase of securities on an exchange or from another person at price $ 1.23 per share. 30 Aug 2021 5,500 179,484 (0%) 0% 1.2 6,760 Common stock
Robert Neal Weingarten Director Grant, award, or other acquisition of securities at price $ 1.14 per share. 20 Aug 2021 10,000 118,750 (0%) 0% 1.1 11,400 Common Stock, $0.001 par value
Donald A. Gagliano Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2021 16,667 16,667 - - Employee Stock Option (right to buy)
Mark Goldstone Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2021 16,667 16,667 - - Employee Stock Option (right to buy)
Kelly J. Anderson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2021 16,667 16,667 - - Employee Stock Option (right to buy)
Robert Neal Weingarten Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2021 16,667 16,667 - - Employee Stock Option (right to buy)
Craig Sheehan Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2021 50,000 50,000 - - Restricted Stock Units
Craig Sheehan Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2021 50,000 50,000 - - Employee Stock Option (right to buy)
Bret Scholtes Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2021 916,023 916,023 - - Employee Stock Option (right to buy)
Mark Goldstone None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Aug 2020 250,000 250,000 - - Stock option (right to buy)
Kelly Anderson None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Aug 2020 250,000 250,000 - - Stock option (right to buy)
Robert Neal Weingarten None Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Aug 2020 250,000 250,000 - - Stock option (right to buy)
Andrew C. Schmidt Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jul 2020 1,000,000 1,000,000 - - Stock Option
Donald A. Gagliano None Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2020 100,000 100,000 - - Stock Option
David W. Evans Director, Interim CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2020 100,000 100,000 - - Stock Option
Mark Goldstone None Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2020 100,000 100,000 - - Stock Option
Kelly Anderson None Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2020 100,000 100,000 - - Stock Option
Robert Neal Weingarten None Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jun 2020 100,000 100,000 - - Stock Option
David W. Evans Director, Chief Science Officer Grant, award, or other acquisition of securities at price $ 0.33 per share. 28 Oct 2019 2,000 1,544,500 (2%) 0% 0.3 664 Common Stock
David W. Evans Director, Chief Science Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Oct 2019 2,000 2,000 - - Warrant
David W. Evans Director, Chief Science Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Aug 2019 20,000 1,542,500 (2%) 0% - Common Stock
David W. Evans Director, Chief Science Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Aug 2019 20,000 20,000 - - Warrant
David W. Evans Director, Chief Science Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 15 Aug 2019 20,000 0 - - Warrant
David W. Evans Director, Chief Science Officer Grant, award, or other acquisition of securities at price $ 0.44 per share. 15 Aug 2019 20,000 1,522,500 (2%) 0% 0.4 8,800 Common Stock
Donald A. Gagliano Director Grant, award, or other acquisition of securities at price $ 3.55 per share. 09 Apr 2019 250 136,500 (0%) 0% 3.6 888 Common stock
David W. Evans Director, Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 4.00 per share. 09 Apr 2019 6,500 1,502,500 (2%) 0% 4 26,000 Common Stock
Michael Favish Director, Chief Executive Officer, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Apr 2019 1,250,000 1,250,000 - - Stock Option (Right to Buy)
Michael Favish Director, Chief Executive Officer, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 4.00 per share. 09 Apr 2019 1,000 1,000 (0%) 0% 4 4,000 Common Stock
Robert Neal Weingarten Director Grant, award, or other acquisition of securities at price $ 4.00 per share. 09 Apr 2019 2,500 652,500 (0%) 0% 4 10,000 Common Stock
Donald A. Gagliano Director Grant, award, or other acquisition of securities at price $ 4.00 per share. 09 Apr 2019 1,250 136,250 (0%) 0% 4 5,000 Common stock
Mark Goldstone Director Grant, award, or other acquisition of securities at price $ 3.53 per share. 08 Apr 2019 300 525,300 (0%) 0% 3.5 1,060 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters